Editorial: Women in obstetric and pediatric pharmacology: 2023.

This document is an editorial published in Frontiers in Pharmacology titled "Women in obstetric and pediatric pharmacology: 2023." The editorial addresses the global disparity in gender representation within the field of research, particularly in science, where less than 30% of researchers worldwide are women. It highlights the barriers and biases that women in science face, leading many talented female researchers to leave the scientific community. The editorial aims to showcase the contributions of female researchers in obstetric and pediatric pharmacology to address these inequities and promote the work of women scientists in the field. The document also includes summaries of several research studies on topics such as preeclampsia, hydroxychloroquine for preeclampsia treatment, ustekinumab use in pediatric Crohn's disease, and the relationship between preterm birth and postpartum depression. These studies emphasize the importance of understanding and addressing various health issues related to obstetric and pediatric pharmacology. [Extracted from the article]